1. Home
  2. VCEL vs ICHR Comparison

VCEL vs ICHR Comparison

Compare VCEL & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$35.06

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$63.97

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
ICHR
Founded
1989
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
VCEL
ICHR
Price
$35.06
$63.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$57.75
$49.50
AVG Volume (30 Days)
702.1K
615.0K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
N/A
EPS
0.32
N/A
Revenue
$276,259,000.00
$947,652,000.00
Revenue This Year
$19.10
$19.98
Revenue Next Year
$17.95
$15.92
P/E Ratio
$110.64
N/A
Revenue Growth
16.45
11.61
52 Week Low
$28.95
$13.15
52 Week High
$45.97
$65.58

Technical Indicators

Market Signals
Indicator
VCEL
ICHR
Relative Strength Index (RSI) 58.72 73.34
Support Level $34.26 $15.58
Resistance Level $38.48 N/A
Average True Range (ATR) 1.37 3.52
MACD 0.46 1.60
Stochastic Oscillator 94.67 93.58

Price Performance

Historical Comparison
VCEL
ICHR

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

Share on Social Networks: